BOSTON (AP) — A drug company subsidiary has pleaded guilty to fraud charges stemming from allegations that the manufacturer schemed to bribe doctors to prescribe its highly addictive fentanyl spray. The guilty plea entered in Boston federal court Friday by Insys Therapeutics’ operating unit is part of a settlement announced this week to resolve investigations... Read More
